Thus, patients with heterozygous CUL3 pathogenic variants are more likely to develop severe hyperkalemia, metabolic acidosis, hypertension, and growth impairment at an early stage than individuals carrying recessive KLHL3, dominant KLHL3, WNK4, or WNK1 pathogenic variants [6]. The gene discussed is WNK4; the disease is Hypertension.